Thu, August 1, 2024

Balaji Prasad Maintained (TEVA) at Buy with Increased Target to $22 on, Aug 1st, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-increased-target-to-22-on-aug-1st-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Balaji Prasad of Barclays, Maintained "Teva Pharmaceutical Industries Limited" (TEVA) at Buy with Increased Target from $21 to $22 on, Aug 1st, 2024.

Balaji has made no other calls on TEVA in the last 4 months.



There are 4 other peers that have a rating on TEVA. Out of the 4 peers that are also analyzing TEVA, 0 agree with Balaji's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Balaji


  • Ashwani Verma of "UBS" Maintained at Strong Buy with Increased Target to $24 on, Wednesday, July 10th, 2024
  • Glen Santangelo of "Jefferies" Maintained at Strong Buy with Increased Target to $23 on, Thursday, June 27th, 2024
  • Jason Gerberry of "B of A Securities" Maintained at Strong Buy with Increased Target to $21 on, Thursday, May 30th, 2024
  • David Amsellem of "Piper Sandler" Reiterated at Buy with Increased Target to $20 on, Monday, May 13th, 2024

Publication Contributing Sources